KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Shares Issued (2016 - 2023)

Opko Health's Shares Issued history spans 14 years, with the latest figure at -$545000.0 for Q4 2023.

  • For Q4 2023, Shares Issued rose 62.72% year-over-year to -$545000.0; the TTM value through Dec 2023 reached -$1.6 million, down 103.1%, while the annual FY2023 figure was -$272000.0, 64.86% up from the prior year.
  • Shares Issued reached -$545000.0 in Q4 2023 per OPK's latest filing, down from -$28000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $76.1 million in Q4 2019 to a low of -$1.5 million in Q4 2022.
  • Average Shares Issued over 5 years is $5.5 million, with a median of $112500.0 recorded in 2022.
  • Peak YoY movement for Shares Issued: surged 131.03% in 2021, then plummeted 827.36% in 2022.
  • A 5-year view of Shares Issued shows it stood at $76.1 million in 2019, then tumbled by 99.89% to $87000.0 in 2020, then soared by 131.03% to $201000.0 in 2021, then tumbled by 827.36% to -$1.5 million in 2022, then surged by 62.72% to -$545000.0 in 2023.
  • Per Business Quant, the three most recent readings for OPK's Shares Issued are -$545000.0 (Q4 2023), -$28000.0 (Q3 2023), and -$1.5 million (Q4 2022).